Evaluation of Mustakarishta in the management of Grahani (~Irritable bowel syndrome): A prospective, multicenter, single-arm clinical study
International Journal of Ayurveda Research · 2026-10 · 7 (4) · 509-518
DOI: 10.4103/ijar.ijar_264_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Ayurveda Research, online erschienen am 20.11.2026. Verfasst von Gurucharan Bhuyan und 11 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Grahani is an Ayurvedic disorder characterized by altered digestive function. Its clinical presentation shares several similarities with Irritable Bowel Syndrome (IBS), particularly altered bowel habits and abdominal discomfort. Mustakarishta , a classical Ayurvedic formulation, has been traditionally used in the management of Grahani .
Aim
The aim of this study was to evaluate the clinical efficacy and safety of Mustakarishta in patients diagnosed with Grahani. Materials and Methods: A total of 100 adults (18–65 years) with Grahani were enrolled in this multicenter, open-label clinical study and received 25 ml of Mustakarishta twice daily after food for 12 weeks, followed by a two-week follow-up. Efficacy was assessed using parameters, such as bowel habits, abdominal pain, and Quality of Life (QoL), while safety was evaluated through routine laboratory investigations.
Results
Administration of Mustakarishta resulted in significant improvement in the clinical features of Grahani , with reductions in abdominal pain (71.1%–5.6%), postprandial urgency for defecation (96.7%–12.2%), and mixed bowel pattern (73.3%–5.6%) over the 14-week study period. Significant improvements were also observed across all domains of the IBS-QoL questionnaire ( P < 0.001), indicating enhanced QoL. The intervention was well tolerated, with no treatment-related adverse events reported, and routine laboratory parameters remained within normal limits throughout the study.
Conclusion
Mustakarishta appears to be a safe and effective intervention for the management of Grahani . However, larger multicenter randomized controlled trials are needed to establish its long-term efficacy and generalizability.
Zitieren
APA
Bhuyan, G., Das, J. R., Rao, S. K., Dogra, E., Singh, R., Khanduri, S., Sharma, B. S., Rana, R., Tripathi, A., Rao, M. M., Rao, B. C., & Srikanth, N. (2026). Evaluation of Mustakarishta in the management of Grahani (~Irritable bowel syndrome): A prospective, multicenter, single-arm clinical study. International Journal of Ayurveda Research, 7(4), 509-518. https://doi.org/10.4103/ijar.ijar_264_25
Vancouver
Bhuyan G, Das JR, Rao SK, Dogra E, Singh R, Khanduri S, et al. Evaluation of Mustakarishta in the management of Grahani (~Irritable bowel syndrome): A prospective, multicenter, single-arm clinical study. International Journal of Ayurveda Research. 2026;7(4):509-518. doi:10.4103/ijar.ijar_264_25
BibTeX
@article{Bhuyan2026,
author = {Bhuyan, Gurucharan and Das, Jeuti Rani and Rao, S. Krishna and Dogra, Ekta and Singh, Renu and Khanduri, Shruti and Sharma, Bhagwan Sahai and Rana, Rakesh and Tripathi, Arunabh and Rao, Meda Mruthyumjaya and Rao, B. Chandrashekhar and Srikanth, Narayanam},
title = {Evaluation of Mustakarishta in the management of Grahani (~Irritable bowel syndrome): A prospective, multicenter, single-arm clinical study},
journal = {International Journal of Ayurveda Research},
year = {2026},
volume = {7},
number = {4},
pages = {509--518},
doi = {10.4103/ijar.ijar_264_25}
}
EUVIMED